Insulin products and patents in the USA in 2004, 2014, and 2020: a cross-sectional study

Lancet Diabetes Endocrinol. 2023 Feb;11(2):73-75. doi: 10.1016/S2213-8587(22)00354-0.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cross-Sectional Studies
  • Humans
  • Insulin* / therapeutic use

Substances

  • Insulin